跳至主要内容
临床试验/ACTRN12617000988358
ACTRN12617000988358已完成2 期

The physiological effects of high dose zopiclone in people with obstructive sleep apnoea

euroscience Research Australia0 个研究点目标入组 30 人开始时间: 2017年7月10日最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 64 Years(—)
性别
All

入选标准

  • Otherwise healthy, men and women with obstructive sleep apnoea
  • Patients who have a low respiratory arousal threshold (between zero and -15cmH2O epiglottic pressure just prior to arousal) as estimated from their baseline sleep study.

排除标准

  • Patients with confirmed overnight blood oxygen saturation nadir (SaO2) less than 70% from baseline sleep study
  • Patients with a high arousal threshold (less than -25cmH2O epiglottic pressure prior to arousal)
  • Patients taking medications known to affect sleep or muscle activity
  • Women lactating, pregnant or of childbearing potential who are not willing to avoid becoming pregnant during the study
  • Patients with any other medical condition which may interfere in the evaluation of the study

研究者

发起方
euroscience Research Australia

相似试验